Athyrium Opportunities IV Acquisition 2 LP

Insider Reports History

Location
New York, NY
Signature
/s/ Athyrium Opportunities IV Acquisition 2 LP, by Athyrium Opportunities Associates IV LP, its General Partner, by Athyrium Opportunities Associates IV GP LLC, its General Partner, by Andrew Hyman, Senior Vice President, Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Athyrium Opportunities IV Acquisition 2 LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
RVL Pharmaceuticals plc 10%+ Owner Ordinary Shares 6,451,612 $201,290 $0.0312 08 Aug 2022 Indirect

Insider Reports Filed by Athyrium Opportunities IV Acquisition 2 LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322028442-athyrium-opportunities-iv-acquisition-2-lp-2022-08-08 RVL Pharmaceuticals plc 08 Aug 2022 0 $0 3 10%+ Owner 12 Aug 2022, 11:37